ESMO

Presidential Symposium will demonstrate how proprietary computational pathology biomarker for TROP2 enhances patient selection and potentially predicts patient outcomes in advanced lung cancer.

Presidential Symposium for NIAGARA will highlight practice-changing impact of a perioperative Imfinzi-based regimen in bladder cancer.

New data demonstrate the connection between heart failure and transthyretin-mediated amyloid cardiomyopathy, underscoring the need for earlier detection and diagnosis.